A cyclically conjugated molecular entity with a stability (due to delocalization) significantly greater than that of a hypothetical localized structure (e.g. Kekule structure) is said to possess aromatic character.
| Member | Definition | Role |
|---|
| 1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | | 1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one |
| 1,3-diphenylpropane | | 1,3-Diphenylpropane |
| 2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol | | 2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol |
| 2',6'-dimethoxychalcone | | 2',6'-dimethoxychalcone |
| 4-dimethylamino-2',4',6'-trimethoxychalcone | | 4-dimethylamino-2',4',6'-trimethoxychalcone |
| CHIC-35 | An organic heterotricyclic compound resulting from the formal fusion of the 2-3 bond of 5-chloroindole with the 2-3 bond of cycloheptanecarboxamide (the S enantiomer). It is a potent, cell-permeable, metabolically stable and selective inhibitor of the deacetylase SIRT1. | CHIC-35 |
| diprafenone | | diprafenone |
| etafenone | | etafenone |
| MMP-9-IN-1 | A secondary carboxamide resulting from the formal condensation of the carboxy group of [(4-oxo-6-propyl-1,4-dihydropyrimidin-2-yl)sulfanyl]acetic acid with the amino group of 4-(difluoromethoxy)aniline. It is a specific matrix metalloproteinase-9 (MMP-9) inhibitor. | MMP-9-IN-1 |
| N-(1,3-diphenylpropan-2-ylideneamino)-2-hydroxybenzamide | | N-(1,3-diphenylpropan-2-ylideneamino)-2-hydroxybenzamide |
| yoda 1 | A member of the class of thiadiazoles that is 1,3,4-thiadiazole substituted by pyrazin-2-yl and (2,6-dichlorobenzyl)sulfanediyl groups at positions 2 and 5, respectively. It is a selective activator of mechanosensitive channel piezo1. | yoda 1 |